About eNeura
eNeura is a company based in Baltimore (United States) founded in 2000. eNeura has raised $70.51 million across 18 funding rounds from investors including Orthofix, Camden Partners and NEA. The company has 17 employees as of December 31, 2022. eNeura offers products and services including sTMS Device and SAVI Smart Diary. eNeura operates in a competitive market with competitors including ElectroCore, ShiraTronics, Salvia BioElectronics, Cefaly and Zosano Pharma, among others.
- Headquarter Baltimore, United States
- Employees 17 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Eneura, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$70.51 M (USD)
in 18 rounds
-
Latest Funding Round
$511.04 K (USD), Series D
Feb 21, 2020
-
Investors
Orthofix
& 4 more
-
Employee Count
17
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of eNeura
eNeura offers a comprehensive portfolio of products and services, including sTMS Device and SAVI Smart Diary.
Non-invasive device that treats and prevents migraines using magnetic pulses.
App that automatically records and monitors migraine treatment history.
Funding Insights of eNeura
eNeura has successfully raised a total of $70.51M across 18 strategic funding rounds. The most recent funding activity was a Series D round of $511.04 thousand completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in eNeura
eNeura has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Orthofix, Camden Partners and NEA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth equity investments are made in lower middle market companies.
|
Locked | Locked | Locked | |
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked | |
|
Investments are made in US life sciences and energy companies.
|
Locked | Locked | Locked |
Investor details for eNeura
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by eNeura
Investment portfolio details for eNeura
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - eNeura
Detailed financials for eNeura
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eneura Comparisons
Peer comparison for eNeura
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of eNeura
eNeura operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ElectroCore, ShiraTronics, Salvia BioElectronics, Cefaly and Zosano Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive vagus nerve stimulation devices are developed for headache treatments.
|
|
| Locked | Locked | Locked |
Neuromodulation devices for migraine and chronic disease treatment are developed.
|
|
| Locked | Locked | Locked |
Bioelectronic solutions for migraines and neurological disorders are developed.
|
|
| Locked | Locked | Locked |
Neurostimulation devices for migraine and headache treatment are provided.
|
|
| Locked | Locked | Locked |
Develops innovative transdermal drug delivery technologies for various therapeutic applications.
|
Detailed competitors of eNeura
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eneura
Complete news archive for eNeura
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about eNeura
eNeura was founded in 2000 and raised its 1st funding round 10 years after it was founded.
eNeura is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
eNeura is a funded company, having raised a total of $70.51M across 18 funding rounds to date.
As of Dec 31, 2022, the latest employee count at eNeura is 17.
eNeura was founded in 2000 and is headquartered in Baltimore, United States. Portable, non-invasive transcranial magnetic stimulation devices are developed by the company for migraine pain relief. An FDA-approved prescription device is provided, allowing patients to self-administer treatments as needed. Operations focus on neuromodulation technology within the medical device sector, targeting chronic headache management.
eNeura's top competitors include Salvia BioElectronics, ShiraTronics and ElectroCore.
eNeura offers sTMS Device and SAVI Smart Diary.
eNeura has 5 investors. Key investors include Orthofix, Camden Partners, NEA, Technology Partners, and Domain Associates.